Clicky

Excelsior Biopharma(6496)

Description: Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to detect influenza virus, fecal occult blood, acute pancreatitis, preterm or full-week delivery, and early water breaking. In addition, the company provides toothpaste, and mouth wash and gel products under the Oral7 name; and food and medical beauty maintenance products. Further, it imports and exports active pharmaceutical ingredients; and engages in the research of technologies, and pharmaceutical technologies transfer and cooperative development and improvement activities. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was incorporated in 1988 and is headquartered in Taipei, Taiwan.


Keywords: Pharmaceutical Products Infectious Diseases Active Pharmaceutical Ingredients Influenza Virus Acute Pancreatitis Gel Products Healthcare Food Products

Home Page: www.excelsiorgroup.com.tw

No.3, Park Street
Taipei, 11503
Taiwan
Phone: 886 2 2655 7568


Officers

Name Title
Mr. Joseph Chen Founder, Chairman, Pres & GM
Mr. MingTse Chen Financial Mang. & Chief Accountant
Ms. HuiChen Liu Representative Director & Admin. Department Mang.
Mr. Po-Tang Cheng Sr. Sales Director
Ms. Chialing Chen Representative Director, New Bus. Devel. Mang. & Associate Manger to the Pres Office

Exchange: TWO

Country: TW

Currency: New Taiwan Dollar (NT$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.0937
Price-to-Sales TTM: 1.5053
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks